Search Results - "VILSENDORF, ZU"

Refine Results
  1. 1

    Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties by Barth, Maximilian, Rudolph, Stefan, Kampschulze, Jan, Meyer zu Vilsendorf, Imke, Hanekamp, Walburga, Mulac, Dennis, Langer, Klaus, Lehr, Matthias

    Published in ChemMedChem (04-05-2022)
    “…A series of hexafluoroisopropyl carbamates with indolylalkyl‐ and azaindolylalkyl‐substituents at the carbamate nitrogen was synthesized and evaluated for…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Quality of life in adult transplant recipients more than 15 years after kidney transplantation by NEIPP, Michael, KARAVUL, Behya, JACKOBS, Steffan, MEYER ZU VILSENDORF, Andreas, RICHTER, Nicolas, BECKER, Thomas, SCHWARZ, Anke, KIEMPNAUER, Juergen

    Published in Transplantation (27-06-2006)
    “…With continuously rising survival rates following renal transplantation, health-related quality of life (HQOL) of long-term transplant survivors becomes…”
    Get full text
    Journal Article
  5. 5

    Diabetes Prevention by Immunomodulatory FTY720 Treatment in the LEW.1AR1-iddm Rat Despite Immune Cell Activation by Jörns, Anne, Rath, Klaus Jan, Terbish, Taivankhuu, Arndt, Tanja, Meyer zu Vilsendorf, Andreas, Wedekind, Dirk, Hedrich, Hans-Jürgen, Lenzen, Sigurd

    Published in Endocrinology (Philadelphia) (01-08-2010)
    “…The prevention of diabetes by the immunomodulatory agent FTY720 (fingolimod) was studied in the LEW.1AR1-iddm (IDDM) rat, an animal model of human type 1…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Intracardiac impedance monitors stroke volume in resynchronization therapy patients by Bocchiardo, Mario, Meyer zu Vilsendorf, Dorothee, Militello, Carmelo, Lippert, Michael, Czygan, Gerald, Gaita, Fiorenzo, Schauerte, Patrick, Stellbrink, Christoph

    Published in Europace (London, England) (01-05-2010)
    “…Monitoring of haemodynamic parameters or surrogate parameters of the left ventricle is especially important for patients under cardiac resynchronization…”
    Get full text
    Journal Article
  8. 8
  9. 9

    A case of successful renal transplantation for hydatid disease after surgical treatment of disseminated cysts by Özdemir, M., Ringe, K.I., Schrem, H., Kleine, M., Meyer zu Vilsendorf, A., Klempnauer, J., Lehner, F., Jäger, M., Bektas, H.

    Published in Transplant infectious disease (01-06-2015)
    “…Hydatid disease is a systemic disorder affecting especially the liver and lungs. Although it is not endemic in Europe, it can be seen sporadically,…”
    Get full text
    Journal Article
  10. 10

    Induction of Heme Oxygenase-1 Improves the Survival of Pancreas Grafts by Prevention of Pancreatitis After Transplantation by BECKER, Thomas, ZU VILSENDORF, Andreas Meyer, TERBISH, Taivankhuu, KLEMPNAUER, Jürgen, JORNS, Anne

    Published in Transplantation (27-12-2007)
    “…Ischemia/reperfusion (I/R) injury after pancreas transplantation might result in graft pancreatitis. The role of heme oxygenase-1 (HO-1) in pancreas…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Resynchronization therapy optimization by intracardiac impedance by Bocchiardo, Mario, Meyer zu Vilsendorf, Dorothee, Militello, Carmelo, Lippert, Michael, Czygan, Gerald, Schauerte, Patrick, Gaita, Fiorenzo, Stellbrink, Christoph

    Published in Europace (London, England) (01-11-2010)
    “…For successful cardiac resynchronization therapy (CRT), an optimization of left ventricular (LV) lead position and stimulation timing is required. The…”
    Get full text
    Journal Article
  13. 13

    Living donor nephrectomy: Flank incision versus anterior vertical mini-incision by NEIPP, Michael, JACKOBS, Steffan, BECKER, Thomas, MEYER ZU VILSENDORF, Andreas, WINNY, Markus, LUECK, Rainer, KLEMPNAUER, Juergen, NASHAN, Bjorn

    Published in Transplantation (15-11-2004)
    “…Currently, many centers perform laparoscopic donor nephrectomy (DN). We studied the outcome of donors and recipients following open DN using either flank…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Transcoronary Ablation of Septal Hypertrophy Does Not Alter ICD Intervention Rates in High Risk Patients with Hypertrophic Obstructive Cardiomyopathy by LAWRENZ, THORSTEN, OBERGASSEL, LUDGER, LIEDER, FRANK, LEUNER, CHRISTIAN, STRUNK-MUELLER, CLAUDIA, MEYER, DOROTHEE, VILSENDORF, ZU, BEER, GERALD, KUHN, HORST

    Published in Pacing and clinical electrophysiology (01-04-2005)
    “…Introduction: Transcoronary ablation of septal hypertrophy (TASH) is safe and effectively reduces the intraventricular gradient in patients with hypertrophic…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Leadless pacemakers and subcutaneously implantable cardioverter defibrillators by Stellbrink, C, Hansky, B, Meyer Zu Vilsendorf, D

    Published in Der Internist (Berlin) (01-10-2018)
    “…Although pacemakers and implantable defibrillators have become the standard treatment of bradycardic and tachycardic arrhythmias, long-term complications…”
    Get full text
    Journal Article
  20. 20

    Guinea pig C3 specific rabbit single chain Fv antibodies from bone marrow, spleen and blood derived phage libraries by Hawlisch, Heiko, Meyer zu Vilsendorf, Andreas, Bautsch, Wilfried, Klos, Andreas, Köhl, Jörg

    Published in Journal of immunological methods (06-03-2000)
    “…We constructed combinatorial immunoglobulin libraries from the whole rabbit antibody repertoire of bone marrow, spleen and peripheral blood of a rabbit…”
    Get full text
    Journal Article